2013年，福建医科大学药学专业，学士学位；
2016年，福建医科大学生物信息专业，硕士学位；
2019年，beat365正版唯一官网生物信息专业，博士学位；
2019年，beat365正版唯一官网，助理教授；
2021年，beat365正版唯一官网，特任副研究员。
B.S. 2013, Fujian Medical University, Pharmacy;
M.S. 2016, Fujian Medical University, Bioinformatics;
Ph.D. 2019, Tsinghua University, Bioinformatics;
Assistant Professor, School of Life Sciences, Xiamen University, 2019 to Present.

主要从事肿瘤生物信息转化医学研究，具体内容如下:
(1)利用生物信息学技术分析多维组学数据(基因组/转录组/表观基因组/单细胞转录组/单细胞质谱成像等)，筛选肿瘤分子标志物与药物靶点
(2)肿瘤蛋白质组和磷酸化组质谱数据个体化分析
(3)蛋白质修饰功能预测
(1)Using bioinformatics technology to identify cancer biomarkers and drug targets based on multi-omics data (genome; transcriptome; epigenome; sc-RNAseq; IMC)
(2) Individualized analysis of cancer proteome and phosphoproteome
(3) Functional prediction of protein modifications

代表性论文(^# co-first author, ^* Corresponding author):

1.Yachen Liu , Yalan Lin, Yuxiang Lin, Yujuan,Wu, Zheyang Zhang, Nuoqi Lin, Xianlong Wang, Mengsha Tong^*, Rongshan Yu^*. Application of individualized differential expression analysis in human cancer proteome. Briefings in Bioinformatics, 2022 Apr 2;bbac096.
2.Mengsha Tong^#; Chunyu Yu^#; Jinwen Shi^#; Wenwen Huang^#; Sai Ge^#; Mingwei Liu; Lei;Song; Dongdong Zhan; Xia Xia;Wanlin Liu; Jinwen Feng; Wenhao Shi;Jiafu Ji; Jing Gao; Tieliu Shi; Weimin Zhu;Chen Ding; Yi Wang; Fuchu He^*; Lin Shen^*; Tingting Li^*; Jun Qin^*; Phosphoproteomics Enables Molecular Subtyping and Nomination of Kinase Candidates for Individual Patients of Diffuse-Type Gastric Cancer, iScience, 2019, 22: 44–57.
3.Mengsha Tong^#; Chunyu Yu ^#; Dongdong Zhan; Ming Zhang; Bei Zhen; Weimin Zhu; Yi Wang; Congying Wu; Fuchu He^*; Jun Qin^*; Tingting Li^*; Molecular subtyping of cancer and nomination of kinase candidates for inhibition with phosphoproteomics: reanalysis of CPTAC ovarian cancer, EBioMedicine, 2018, 40 (2352-3964): 305-317.
4.Mengsha Tong^#; Weicheng Zheng^#; Hongdong Li; Xiangyu Li; Lu Ao; Yifeng Shen; Qirui Liang; Jing Li; Guini Hong; Haidan Yan; Hao Cai; Mengyao Li; Qingzhou Guan; Zheng Guo^*; Multi-omics landscapes of colorectal cancer subtypes discriminated by an individualized prognostic signature for 5-fluorouracil-based chemotherapy, Oncogenesis, 2016, 5(2157-9024).
5.Yifeng Shen^#; Mengsha Tong^#; Qirui Liang; Huaqin Sun; Weicheng Zheng; Lu Ao; Zheng Guo^*; Feifei She^*; Epigenomics alternations and dynamic transcriptional changes in responses to 5-fluorouracil stimulation reveal mechanisms of acquired drug resistance of colorectal cancer cells, The Pharmacogenomics Journal 2017, 18 (1470-269X): 23-28.
6.GaiGai Guo, Zhouyong Gao, Mengsha Tong, Dongdong Zhan, Guangshun Wang, Yi Wang, Jun Qin^*. NQO1 is a determinant for cellular sensitivity to anti-tumor agent. Napabucasin American Journal of Cancer Research 2020; 10(5):1442-1454

荣誉、奖励及参加学术团体的情况:

福建省引进高层次人才(国内B类)
厦门市高层次人才(C类)
福建省生物信息学学会 办公室主任